New
Actonel 150 mg Once-a-month
The first and only once-a-month dosing option in Canada for the treatment of postmenopausal osteoporosis.

Help protect her from fracture by prescribing Actonel

Brand name: Actonel
Generic name/category: Risedronic acid, bisphosphonate
Company: Sanofi-Aventis and Procter & Gamble
Country/Market: Canada, North America
Indication(s)/use: postmenopausal osteoporosis
Target: Healthcare Professionals (HCP)
Tagline: Focused on fracture
Publication: The Canadian Journal of Diagnosis June 2009

To see all of the ads from this campaign, click here
To see all of this brand’s ads on AdPharm, click here